유전성 질환 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Hereditary Testing Market size is expected to reach USD 17.94 Billion in 2034 from USD 8.31 Billion (2025) growing at a CAGR of 8.93% during 2026-2034.

The global hereditary testing market is witnessing rapid growth due to increasing awareness of genetic disorders and the importance of early diagnosis. Hereditary testing helps identify genetic mutations associated with inherited diseases, enabling preventive healthcare and personalized treatment plans. The growing focus on precision medicine is a major driver of market expansion.

Key drivers include advancements in genetic sequencing technologies, declining costs of testing, and rising adoption of direct-to-consumer genetic tests. Healthcare providers are increasingly recommending hereditary testing for conditions such as cancer, cardiovascular diseases, and rare genetic disorders. Government initiatives promoting genetic research are also supporting market growth.

Looking ahead, the market is expected to expand with the integration of AI and big data analytics in genetic analysis. Increased accessibility and awareness in emerging regions will further boost adoption. As personalized healthcare becomes more prominent, hereditary testing will play a critical role in disease prevention and management.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Hereditary Cancer Testing
• Hereditary Non-cancer Testing

By Technology

• Cytogenetic
• Biochemical
• Molecular Testing

COMPANIES PROFILED

• Myriad Genetics Inc, Invitae Corporation, Illumina, Inc, Natera, Inc, Laboratory Corporation of America Holdings, F HoffmannLa Roche Ltd, Quest Diagnostics Incorporated, CooperSurgical Inc, Agilent Technologies Inc, Thermo Fisher Scientific, Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEREDITARY TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Hereditary Cancer Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hereditary Non-cancer Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEREDITARY TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Cytogenetic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biochemical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Molecular Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEREDITARY TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By Technology
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By Technology
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By Technology
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By Technology
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By Technology
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HEREDITARY TESTING INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Myriad Genetics Inc
  • 8.2.2 Invitae Corporation
  • 8.2.3 IlluminaInc
  • 8.2.4 NateraInc
  • 8.2.5 Laboratory Corporation Of America Holdings
  • 8.2.6 F. Hoffmann-La Roche Ltd
  • 8.2.7 Quest Diagnostics Incorporated
  • 8.2.8 CooperSurgical Inc
  • 8.2.9 Agilent Technologies Inc
  • 8.2.10 Thermo Fisher ScientificInc